RheumNow Podcast - ACR Convergence Begins
Dr Cush reviews the news and kicks off ACR21 learning and how to take in the annual meeting

Dr Cush reviews the news and kicks off ACR21 learning and how to take in the annual meeting
QD148 - Severe Arthritis Numbers and Associations QD149 - The Thyroid Lump QD150 - Alopecia Rules QD151 - Half Baked Blogs QD152 - Who is Immunosuppressed?
Dr. Jack Cush reviews the news and journal articles from the past week and discusses parent-child rheumatologists pairs
Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com
Dr. Jack Cush reviews the FDA approvals, news and the latest journal articles from the past week on RheumNow.com
Dr Jack Cush reviews the news and journal reports from this past week on RheumNow.com; plus questions & cases from viewers in (#ACA) Ask Cush Anything.
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections during f...
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Study of 435 #SLE pts seen during the pandemic. Comparing those seen F2F vs telemedicine, there was no significant difference in SLE disease activity (by SLEDAI-2K) or SLE flare rates or steroid ...
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Metanalysis of JAK inhibition (tofacitinib & ruxolitinib) in alopecia areata - 12 studies, 346 Pts, Rx success (using SALT50 resp) was 66%, not influenced by age, sex, subtype. Alopecia recur...
Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com
Dr. Jack Cush is joined by Drs. Kathryn Dao (Dallas), Rachel Tate (Palm Beach), William Shergy (Huntsville) and Jeffrey Sparks (Boston)
Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com
Dr. Jack Cush is joined by Drs. Roy Fleischmann (Dallas), Allan Gibofsky (NYC), and Artie Kavanaugh (San Diego)
Dr. Jack Cush reviews the news, journal reports and cautions regarding COVID-19
Dr. Jack Cush reviews the news, journal articles and more from this past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com
Dr Jack Cush reviews the news, journal reports and FDA approvals from the past week on RheumNow.com
Dr Jack Cush reviews rheumatology and COVID news from the past week on RheumNow.com
Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Dr. Jack Cush Reviews this weeks news and journal reports featured on RheumNow.com
Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!
Dr. Jack Cush reviews his highlight favorite abstracts and presentations from last weeks viirtual EULAR 2021 meeting
Dr. Jack Cush reviews highlight presentations from Virtual EULAR 2021
What does Scleroderma with ScL70 Look Like_ with Dr. Janet Pope, EULAR 2021 Abatacept in RA ILD_ Dr. Richard Conway Combined Analysis of Peripheral Blood + Synovial Tissue in Early RA_ Dr. Aurelie Najm Comparative Effectiveness_ Registries or Real Life_ Dr. Jonathan Kay Gender, Racial Disparities in PsA Patients_ Dr. Rachel Tate How to Watch EULAR 2021 with Dr. Jack Cush
Iberdomide_ A Novel Drug for Lupus_ Dr. Kathryn Dao IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus_ Drs. Yusof and Carter Impact of Pandemic on Rheumatology Training_ Drs. Dao and Young Impact of RA on Male Fertility_ New Data with Dr. Aurelie Najm, EULAR 2021 MUC5B and Lung Disease in RA_ Dr. Richard Conway New 2021 GRAPPA Treatment Guidelines for Adult PsO and PsA Patients with Dr. Rachel Tate, EULAR 2021 Predictors of PSA Development in Psoriasis Patients_ Drs. Stud...
Pregnancy and Disease Activity in RA with Dr. Richard Conway, EULAR 2021 Prevalence of Long Term HCQ in Retinal Toxicity_ Dr. Kathryn Dao Prospective Study of Complement Levels in Lupus Pregnancy_ Dr. Kathryn Dao Psoriatic Arthritis Highlights from EULAR21_ Dr. Jack Cush RA and Cardiovascular Risks_ Dr. Richard Conway RA_ Don't forget the Lungs_ Dr. Najm and Dr. Juge Rheumatoid Arthritis and Cancer_ Myth or Reality_ Dr. Jonathan Kay Rituximab + Belimumab for SLE_ Dr. Yuz Yusof
Serious Infection Risk from the Filgotinib Drug Development Program_ Dr. James Galloway Spacing Anti-TIF Inhibitors for Axial SpA_ Dr. Eric Dein The Future of Treatment of RA-ILD_ Dr. David Liew Three New Medications for Lupus_ Dr. Eric Dein Treatment Options for SpA Patients and Many Outcomes to be Considered in the Evaluation, EULAR 2021 What Does Limited Scleroderma with ScL70 Look Like_ Dr. Janet Pope A Woman with Lupus Contemplates Pregnancy_ Dr. Janet Pope
Fecal Transplantation as Potential PsA Treatment_ Dr. Eric Dein How to Measure Success in Lupus_ Dr. Kathryn Dao How to Treat SpA with Dr. Robert Chao, EULAR 2021 PROs in Spa and PSA_ Dr. Rachel Tate Sex Differences in Autoimmune Disease Susceptibility_ Drs. Yusof and Robinson SLE Molecular Phenotype for Personalized Medicine_ Drs. Yusof and Garantziotis